These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38125294)

  • 21. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
    Türk M; Yılmaz İ; Nazik Bahçecioğlu S; Can P; Ertaş R; Kartal D; Çınar SL; Kocatürk E
    Dermatol Ther; 2021 Jan; 34(1):e14543. PubMed ID: 33190334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
    Giménez-Arnau AM
    Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.
    Marín-Cabañas I; Berbegal-de Gracia L; de León-Marrero F; Hispán P; Silvestre JF
    Actas Dermosifiliogr; 2017 May; 108(4):346-353. PubMed ID: 28219634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.
    Lapeere H; Baeck M; Stockman A; Sabato V; Grosber M; Moutschen M; Lambert J; Vandebuerie L; de Montjoye L; Rabijns H; Allewaert K; Schrijvers R
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):127-134. PubMed ID: 31099916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort.
    Rauscher C; Petrov AA; Fajt ML
    Curr Drug Saf; 2021; 16(1):97-100. PubMed ID: 33006537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria.
    Metz M; Bernstein JA; Giménez-Arnau AM; Hide M; Maurer M; Sitz K; Soong W; Sussman G; Hua E; Barve A; Barbier N; Balp MM; Severin T
    World Allergy Organ J; 2022 Nov; 15(11):100716. PubMed ID: 36440464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert consensus on the use of omalizumab in chronic urticaria in China.
    Zhao Z; Cai T; Chen H; Chen L; Chen Y; Gao X; Gao X; Geng S; Guo Y; Hao F; Hao G; Hu Y; Jin H; Jin Z; Li C; Li H; Li J; Li Y; Liang Y; Liu G; Liu Q; Long H; Ma L; Shang Y; Song Y; Song Z; Su X; Sui H; Sun Q; Sun Y; Tang J; Tong X; Wang H; Wang G; Wang L; Wang S; Xiang L; Xiao T; Xie Z; Ye L; Yu Y; Zhang C; Zhang L; Zhang S; Zheng R; Zhi L; Zhou W; Zou Y; Maurer M
    World Allergy Organ J; 2021 Nov; 14(11):100610. PubMed ID: 34934470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination.
    Kan AKC; Wong TTH; Chiang V; Lau CS; Li PH
    Allergy Asthma Immunol Res; 2023 Jan; 15(1):32-42. PubMed ID: 36693356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
    Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel.
    Silvestre Salvador JF; Giménez-Arnau AM; Gómez de la Fuente E; González Del Castillo J; Martínez Virto AM; Miguens Blanco I; Serra-Baldrich E; Llorens P
    Emergencias; 2021 Aug; 33(4):299-308. PubMed ID: 34251143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
    Zazzali JL; Kaplan A; Maurer M; Raimundo K; Trzaskoma B; Solari PG; Antonova E; Mendelson M; Rosén KE
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):370-377.e1. PubMed ID: 27424128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative.
    Maurer M; Abuzakouk M; Al-Ahmad M; Al-Herz W; Alrayes H; Al-Tamemi S; Arnaout R; Binghadeer H; Gutta R; Irani C; Mobayed H; Nasr I; Shendi H; Zaitoun F
    World Allergy Organ J; 2023 Jan; 16(1):100729. PubMed ID: 36601261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response.
    Özçeker D; Can PK; Terzi Ö; Ornek SA; Değirmentepe EN; Kızıltac K; Sarac E; Kocatürk E
    Pediatr Allergy Immunol; 2023 Feb; 34(2):e13925. PubMed ID: 36825740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
    Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urticaria and angioedema.
    Guo C; Saltoun C
    Allergy Asthma Proc; 2019 Nov; 40(6):437-440. PubMed ID: 31690389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approach to Children with Hives.
    Poowuttikul P; Pansare M; Kamat D; Seth D
    Pediatr Ann; 2021 May; 50(5):e191-e197. PubMed ID: 34044707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.
    Kasperska-Zajac A; Jarząb J; Żerdzińska A; Bąk K; Grzanka A
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):320-8. PubMed ID: 26729404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for bradykinin release in chronic spontaneous urticaria.
    Hofman ZLM; van den Elzen MT; Kuijpers J; de Maat S; Hack CE; Knulst AC; Röckmann H; Maas C
    Clin Exp Allergy; 2020 Mar; 50(3):343-351. PubMed ID: 31899843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.